Cargando…
Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2
Proteasescontribute to cancer in many ways, including tumor vascularization and metastasis, and their pharmacological inhibition is a potential anticancer strategy. We report that human endothelial cells (EC) express the trypsinogen 4 isoform of the serine protease 3 (PRSS3), and lack both PRSS2 and...
Autores principales: | Ghilardi, Carmen, Silini, Antonietta, Figini, Sara, Anastasia, Alessia, Lupi, Monica, Fruscio, Robert, Giavazzi, Raffaella, Bani, MariaRosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695067/ https://www.ncbi.nlm.nih.gov/pubmed/26318044 |
Ejemplares similares
-
Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor’s proangiogenic microenvironment
por: Silini, Antonietta, et al.
Publicado: (2011) -
Identification of novel vascular markers through gene expression profiling of tumor-derived endothelium
por: Ghilardi, Carmen, et al.
Publicado: (2008) -
PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer
por: Ghilardi, Carmen, et al.
Publicado: (2022) -
Trypsinogen isoforms in the ferret pancreas
por: Hegyi, Eszter, et al.
Publicado: (2018) -
Usefulness of urinary trypsinogen-2 and trypsinogen activation peptide in acute pancreatitis: A multicenter study in Japan
por: Yasuda, Hiroaki, et al.
Publicado: (2019)